Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 8/20 | 0.40 |
| ▸ | GRIN1 | Q05586 | 8/20 | 0.40 |
| ▸ | GRIN2B | Q13224 | 8/20 | 0.40 |
| ▸ | MAOB | P27338 | 7/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | MAOA | P21397 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2186123 | 0.76 | L3MBTL1 (0.49) | RXRAGRIN1GRIN2BMAOBL3MBTL1 | |
| SCHEMBL2185795 | 0.73 | RXRA (0.32) | RXRAGRIN1GRIN2BGAA | |
| SCHEMBL2187864 | 0.70 | MAPT (0.43) | RXRAGRIN1GRIN2BL3MBTL1GAA | |
| SCHEMBL9281084 | 0.70 | RXRA (0.32) | RXRAGRIN1GRIN2B | |
| Hydrochloric Acid SCHEMBL8468117 | 0.69 | RXRA (0.31) | RXRAGRIN1GRIN2B | |
| SCHEMBL17553576 | 0.69 | ALDH1A1 (0.41) | MAOBL3MBTL1KDM4EMAPTSMN1; SMN2 | |
| SCHEMBL34467352 | 0.68 | RXRA (0.44) | RXRAGRIN1GRIN2BL3MBTL1GAA | |
| SCHEMBL22787155 | 0.67 | L3MBTL1 (0.47) | L3MBTL1GAAMAPT | |
| SCHEMBL1924426 | 0.67 | SCN9A (0.44) | RXRAMAOBMAOAGAAKDM4E | |
| SCHEMBL19962271 | 0.66 | MAPK1 (0.39) | GAAKDM4EMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8008487-B2 | Substituted thieno[2,3-D]pyrimidines as fungicides | DOW AGROSCIENCES LLC (US) | 2011-08-30 | — | — | US | disclosed |
| EP-1802632-B1 | THIENO-PYRIMIDINE COMPOUNDS HAVING FUNGICIDAL ACTIVITY | DOW AGROSCIENCES LLC (US) | 2011-07-13 | — | — | EP | disclosed |
| EP-1802632-A1 | THIENO-PYRIMIDINE COMPOUNDS HAVING FUNGICIDAL ACTIVITY | Dow AgroSciences LLC (US) | 2007-07-04 | — | — | EP | disclosed |
| WO-2006047397-A1 | THIENO-PYRIMIDINE COMPOUNDS HAVING FUNGICIDAL ACTIVITY | DOW AGROSCIENCES LLC (US) | 2006-05-04 | — | — | WO | disclosed |
| US-20060089370-A1 | Thieno-pyrimidine compounds having fungicidal activity | BREWSTER WILLIAM K | 2006-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060089370-A1 | Thieno-pyrimidine compounds having fungicidal activity | TYMP, DPM1, TYMS | RXRA 2701/4885GRIN1 3197/4885GRIN2B 2210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.